Brightseed Completes $68M Series B to Commercialize Novel Hemp Ingredients
Brightseed, a pioneer in tech-based phytonutrient research, announces it has raised $68M in Series B funding to accelerate its plant nutrient discovery and bring new ingredients, including special hemp-derived compounds, to market. The company’s first hemp compounds, NCT and NFT, are derived from upcycled seed hulls and are expected to launch in the next nine months. Hemp may lower fat Using its Forager AI platform, Brightseed is able to identify and map plants’ bioactive compounds and relate them to human health benefits with rapid speed, reports NutraIngredients-USA. Forager technology has so far mapped 2 million plant compounds, including N-trans caffeoyltyramine (NCT) and N-trans-feruloyltyramine (NFT) from hemp hulls. Preclinical research suggests the hemp compounds help to reduce liver fat and regulate lipid levels. To commercialize these …
